Skip to content

Cross-cultural acceptability of interventions that may increase control at the end of life in patients with dementia

Cross-cultural acceptability of interventions that may increase control at the end of life in patients with dementia - CONT-END WP1

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54818
Enrollment
80
Registered
2020-04-10
Start date
2020-07-14
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia major neurocognitive disorder

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: The person with dementia: • has a diagnosis of irreversible dementia established by a physician • has been informed about and is aware of his or her diagnosis • has a family caregiver (spouse, friend, partner, daughter/son, etc.) who is willing to participate in the study • has decision making capacity and is able to communicate through sufficient memory and language • has sufficient capacity of the Dutch or English language to participate in the interview • is able to understand and sign the consent form • has adequate vision and hearing (can be achieved by using corrective lenses and hearing aid if required) • consents to participate. The family caregiver: • is willing and able to participate in the study • the person with dementia they care for is willing and able to participate • is at least 18 years old • has sufficient capacity of the Dutch or English language to participate in the interview • consents to participate. The physician: • practices a specialty that includes provision of end-of-life care for individuals living with dementia • is willing and able to participate in the study • consents to participate.

Exclusion criteria

Exclusion criteria: • The person with dementia is currently affected by a severe psychiatric disorder (e.g., major depression, schizophrenia, substance abuse, PTSD) as diagnosed by a psychiatrist, psychologist, or physician. • The person is expected to die in a few weeks

Design outcomes

Primary

MeasureTime frame
The primary outcome is acceptability (i.e., whether the participants would want the interventions at the end of life; patients for themselves, family caregivers for their loved one, and whether physicians would use it at request). Do not know will be a valid response option.

Secondary

MeasureTime frame
Differences in acceptability between types of interventions, group (role), countries will be investigated, and also, in an explorative manner, associations with other characteristics. Open-ended questions in the interviews will be used to examine, in a qualitative manner, possible ambiguity regarding being in control through the interventions, and as to why and in what situation the respondent feels the interventions are acceptable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)